TERT and cancer: Wu et al. reported that in BRAFV600E-mediated human cancers, such as glioblastoma and thyroid cancer, the GABPA recombinant protein and Sp1 co-activate the mutated TERT promoter, accelerating cancer incidence and development (Batista et al., 2016; Wu et al., 2021).